MedTrace Logo

Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas

NCT04951557 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2021-07-07

No results posted yet for this study

Summary

To conduct a retrospective multicenter cohort study to define benchmark values for best achievable outcomes following transsphenoidal resection of pituitary adenomas.

Conditions

  • Pituitary Adenoma
  • Pituitary Tumor
  • Pituitary Diseases

Interventions

PROCEDURE

Transsphenoidal resection

Transsphenoidal resection of pituitary adenoma

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Richard Drexler, MD · Universitätsklinikum Hamburg-Eppendorf

  • Franz L Ricklefs, MD · Universitätsklinikum Hamburg-Eppendorf

  • Jörg Flitsch, MD · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04951557 on ClinicalTrials.gov